Financhill
Sell
6

CDT Quote, Financials, Valuation and Earnings

Last price:
$2.34
Seasonality move :
-31.36%
Day range:
$2.31 - $2.46
52-week range:
$2.31 - $3,030.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.69x
Volume:
203.7K
Avg. volume:
369.4K
1-year change:
-99.92%
Market cap:
$1.9M
Revenue:
--
EPS (TTM):
-$237.75

Earnings Data

Next earnings date for CDT
Aug 12
2025
Most recent earnings per share
-$19.80
Missed by $19.80
(May 15/2025)
Consensus Estimate
--
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CDT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 -- -- -$19.80 -- --
12/31/2024 Q4 -- -- -$7.95 -- --
11/14/2024 Q3 -- -- -$105.00 -- --
08/12/2024 Q2 -- -- -$105.00 -- --
05/14/2024 Q1 -- -- -$72.15 -- --
12/31/2023 Q4 -- -- -$43.80 -- --
11/20/2023 Q3 -- -- $15.00 -- --
06/30/2023 Q2 -- -- -$35.90 -- --
03/31/2023 Q1 -- -- -$34.63 -- --
12/31/2022 Q4 -- -- -$63.61 -- --
09/30/2022 Q3 -- -- -$19.80 -- --
03/31/2022 Q1 -- -- -$6.36 -- --

Conduit Pharmaceuticals Earnings Questions

  • How Much did Conduit Pharmaceuticals Generate in Revenue Last Quarter?

    Conduit Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Conduit Pharmaceuticals Beat Earnings Last Quarter?

    Conduit Pharmaceuticals announced earnings per share of -$19.80 which represents a miss of analyst forecast a -- per share.

  • Is Conduit Pharmaceuticals Profitable?

    Conduit Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Conduit Pharmaceuticals EPS Next Year?

    Conduit Pharmaceuticals's earnings are forecast to grow from -$307.95 per share to -- per share next year representing an increase of --.

  • When is Conduit Pharmaceuticals's Earnings Date?

    Conduit Pharmaceuticals's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock